WinstonWınston
Back
Varex Imaging Corporation logo

Varex Imaging Corporation

VREX
34
Medical - Devices · Healthcare
Exchange
NASDAQ
Winston Score
34
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jul 3, 2026
How the score breaks down
Quality
Mixed
Growth
Mixed
Cash Flow
Weak
Stability
Mixed
Valuation
Good

Winston Score History

The full picture

Varex Imaging Corporation makes the parts that go inside medical imaging machines, like X-ray tubes and digital detectors. These components are sold to manufacturers who build CT scanners, X-ray systems, and radiation therapy equipment used in hospitals and clinics. Varex is one of the largest independent suppliers of X-ray imaging components in the world.

The company earns revenue by selling hardware — its tubes, detectors, and related parts — to original equipment manufacturers (OEMs) like Siemens Healthineers and Philips, rather than selling directly to hospitals. Varex operates globally, with customers across North America, Europe, and Asia, and generates roughly half a billion dollars in annual revenue. Its competitive position comes from deep technical expertise and long-standing OEM relationships, but the negative operating and return margins signal ongoing profitability pressure, and the company faces risk from pricing competition, slower hospital capital spending, and the need to manage costs while investing in next-generation imaging technology.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+3.7% YoY

YoY Growth Rate

Slow revenue growth

EPS Growth

+117.2% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

1.7%ownership

Flat

Insider ownership roughly steady over the past year

Cash Position

Cash flow positive

$119M cash & investments

Quarterly Free Cash Flow

↓ Burn rate worsening

Company generates more cash than it spends — no dilution risk from fundraising

Growth context

Varex Imaging Corporation is growing revenue at 4% year-over-year. The Winston Score measures business quality today — these growth metrics show what could matter tomorrow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
36.4%
Modest — 36.4% gross margin
Profit after running costs
Operating Margin
10.8%
Modest — 10.8% operating margin
Return on the money invested
ROCE
8.6%
Below par — 8.6% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+5.3%
Slow sales growth (+5.3% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
4/8 quarters
Earnings inconsistent quarter-to-quarter

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
51%
Weak — only 51% of profit becomes cash
Spare cash per sale
FCF Margin
-2.3%
Burning cash (-2.3%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
0.70
Moderate — manageable debt (0.70)
Covers its interest
Interest Cover
1.86x
Dangerous — barely covers interest (1.9x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
35.3x
no trend
Pricey — P/E 35.3

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year
P/E vs Forward
+26.1
GROWING
Earnings expected to grow meaningfully — cheaper on forward P/E (35.3 → 9.2)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial